We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Chemours
CC
$2.63B
| $1.56M | ﹤0.01% |
42,096
-14,809
| -26% | -$539K |
|
927
Waters Corp
WAT
$37.5B
| $1.56M | ﹤0.01% |
6,185
+4,013
| +185% | +$914K |
|
928
TTM Technologies
TTMI
$15B
| $1.55M | ﹤0.01% |
132,222
-15,168
| -10% | -$174K |
|
|
HA
929
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.55M | ﹤0.01% |
59,018
+10,444
| +22% | +$303K |
|
930
HF Sinclair
DINO
$16.1B
| $1.55M | ﹤0.01% |
31,399
-23,510
| -43% | -$1.25M |
|
931
Old Republic International
ORI
$10.1B
| $1.54M | ﹤0.01% |
73,723
-779,742
| -91% | -$16.2M |
|
932
Loews
L
$23.8B
| $1.53M | ﹤0.01% |
31,872
-11,258
| -26% | -$531K |
|
|
GCI
933
DELISTED
Gannett Co., Inc
GCI
| $1.53M | ﹤0.01% |
144,794
-33,307
| -19% | -$360K |
|
|
THS
934
DELISTED
Treehouse Foods
THS
| $1.52M | ﹤0.01% |
23,519
-9,799
| -29% | -$578K |
|
935
Andersons Inc
ANDE
$2.66B
| $1.51M | ﹤0.01% |
46,873
-6,714
| -13% | -$233K |
|
936
Landstar System
LSTR
$7.06B
| $1.51M | ﹤0.01% |
13,790
+432
| +3% | +$45.5K |
|
|
MDR
937
DELISTED
McDermott International
MDR
| $1.51M | ﹤0.01% |
202,540
+28,066
| +16% | +$231K |
|
938
Sherwin-Williams
SHW
$76.6B
| $1.5M | ﹤0.01% |
10,482
-2,316
| -18% | -$322K |
|
939
Saic
SAIC
$4.93B
| $1.49M | ﹤0.01% |
19,322
+1,558
| +9% | +$110K |
|
|
GAP
940
The Gap Inc
GAP
$6.8B
| $1.48M | ﹤0.01% |
56,359
+2,662
| +5% | +$68K |
|
|
AAWW
941
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.48M | ﹤0.01% |
29,177
+899
| +3% | +$45.5K |
|
942
Moelis & Co
MC
$4.88B
| $1.47M | ﹤0.01% |
35,431
+463
| +1% | +$19.8K |
|
943
Copart
CPRT
$25.2B
| $1.46M | ﹤0.01% |
96,472
-359,768
| -79% | -$4.89M |
|
|
TBI
944
Trueblue
TBI
$232M
| $1.46M | ﹤0.01% |
61,803
+7,749
| +14% | +$181K |
|
|
ENDP
945
DELISTED
Endo International plc
ENDP
| $1.46M | ﹤0.01% |
181,638
+36,879
| +25% | +$347K |
|
946
Wabash National
WNC
$541M
| $1.46M | ﹤0.01% |
107,555
+7,197
| +7% | +$102K |
|
947
Polaris
PII
$4.13B
| $1.45M | ﹤0.01% |
17,216
-182
| -1% | -$15.4K |
|
|
HR
948
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.45M | ﹤0.01% |
45,247
+6,434
| +17% | +$202K |
|
949
Moog Inc Class A
MOG.A
$13B
| $1.45M | ﹤0.01% |
16,703
-838
| -5% | -$73K |
|
|
CELG
950
DELISTED
Celgene Corp
CELG
| $1.45M | ﹤0.01% |
15,349
-1,459,699
| -99% | -$128M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.